Journal for ImmunoTherapy of Cancer (Nov 2021)

71 Tumors with higher heterogeneity were associated with superior survival outcome amongst stage I lung cancer patients with low tumor mutational burden (TMB)

  • Young Kwang Chae,
  • Stanislav Fridland

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.071
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.